Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): A pilot randomised controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Jensen, Megan E ^a   Mailhot, Genevieve ^b   Alos, Nathalie ^c   Rousseau, Elizabeth ^c   White, John H ^d   Khamessan, Ali ^e   Ducharme, Francine M ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e Euro Pharm International Canada   (Canada)

Author keywords

Asthma; Child; Diet; Feasibility study; Paediatric; Randomised controlled trial; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CORTICOSTEROID; PLACEBO; VITAMIN D; 25-HYDROXYVITAMIN D; ANTIASTHMATIC AGENT; BIOLOGICAL MARKER; COLECALCIFEROL; VITAMIN;

ADULT; ARTICLE; ASTHMA; BLOOD ANALYSIS; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; HUMAN; HYPERCALCIURIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PILOT STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; TREATMENT DURATION; VITAMIN BLOOD LEVEL; WINTER; AGE; ANALOGS AND DERIVATIVES; BLOOD; DISEASE EXACERBATION; INFANT; ORAL DRUG ADMINISTRATION; QUEBEC; TIME FACTOR; TREATMENT OUTCOME; VIROLOGY;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOMARKERS; CHILD, PRESCHOOL; CHOLECALCIFEROL; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; MALE; PILOT PROJECTS; QUEBEC; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMINS;

EID: 84979284484     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1483-1     Document Type: Article

References (46)

1. Rosychuk RJ, Voaklander DC, Klassen TP, Senthilselvan A, Marrie TJ, Rowe BH. Asthma presentations by children to emergency departments in a Canadian province: a population-based study. Pediatr Pulmonol. 2010;45:985-92.
2. Lougheed MD, Garvey N, Chapman KR, Cicutto L, Dales R, Day AG, et al. The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest. 2006;129:909-17.
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2014. http://www.ginasthma.org/. Accessed 20 Dec 2014.
4. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995;332:133-8.
5. Xepapadaki P, Papadopoulos NG. Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers. Eur Respir J. 2010;36:438-45.
6. Bacharier LB, Phillips BR, Zeiger RS, Szefler SJ, Martinez FD, Lemanske Jr RF, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol. 2008;122:1127-35.
7. Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360:339-53.
8. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics. 2009;123:e519-25.
9. Ducharme FM, Tse SM, Chauhan B. Diagnosis, management, and prognosis of preschool wheeze. Lancet. 2014;383:1593-604.
10. Gupta A, Sjoukes A, Richards D, Banya W, Hawrylowicz C, Bush A, et al. Relationship between serum vitamin D, disease severity and airway remodeling in children with asthma. Am J Respir Crit Care Med. 2011;184:1342-9.
11. Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010;126:52-8.
12. Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DYM. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol. 2010;125:995-1000.
13. Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis. 2013;57:392-7.
14. Majak P, Olszoweic-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127:1294-6.
15. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255-60.
16. Yadav M, Mittal K. Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian J Pediatr. 2014;81:650-4.
17. Holick MF. Vitamin D: a D-Lightful health perspective. Nutr Rev. 2008;66:S182-94.
18. Godel JC, Canadian Paediatric Society, First Nations, Inuit and Metis Health Committee. Vitamin D supplementation: recommendations for Canadian mothers and infants. Paediatr Child Health. 2007;12:583-9.
19. Ducharme FM, Dell S, Radhakrishnan D, Grad R, Watson WM, Yang CM, et al. Diagnosis and management of asthma in preschoolers: a Canadian Thoracic Society and Canadian Pediatric Society position paper. Can Respir J. 2015;22:135-43.
20. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermat. 1988;124:869-71.
21. Ducharme FM, Davis GM, Noya F, Rich H, Ernst P. The Asthma Quiz for Kidz: a validated tool to appreciate the level of asthma control in children. Can Respir J. 2004;11:541-6.
22. van den Ouweland JM, Vogeser M, Bacher S. Vitamin D and metabolites measurement by tandem mass spectrometry. Rev Endocr Metab Disord. 2013;14:159-84.
23. Raymond F, Carbonneau J, Boucher N, Robitaille L, Boisvert S, Wu WK, et al. Comparison of automated microarray detection with real-time PCR assays for detection of respiratory viruses in specimens obtained from children. J Clin Microbiol. 2009;47:743-50.
24. Jacobs B. The Canadian Acute Respiratory Illness and Flu Scale (CARIFS): the design and assessment of a paediatric disease severity measure. (Thesis) Toronto: Toronto: University of Toronto; 1999.
25. Ducharme FM, Jensen ME, Mendelson M, Parkin P, Desplats E, Zhang X, et al. Asthma Flare-up Diary for Young Children (ADYC) to monitor severity of exacerbations. J Allergy Clin Immunol. 2016;137:744-9.
26. Jensen ME, Mendelson MJ, Desplats E, Zhang X, Platt R, Ducharme FM. Caregiver's functional status during a young child's asthma exacerbation: a validated instrument. J Allergy Clin Immunol. 2016;137:782-8.
27. Metz MP. Determining urinary calcium/creatinine cut-offs for the paediatric population using published data. Ann Clinic Biochem. 2006;43:398-401.
28. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a caliper database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58:854-68.
29. Gallo S, Comeau K, Vanstone C, Agellon S, Sharma A, Jones G, et al. Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial. JAMA. 2013;309:1785-92.
30. IOM (Institute of Medicine). Dietary reference intakes for calcium and vitamin D. Washington DC: The National Academies Press; 2011.
31. Zeghoud F, Ben-Mekhbi H, Djeghri N, Garabédian M. Vitamin D prophylaxis during infancy: comparison of the long-term effects of three intermittent doses (15, 5, or 2.5 mg) on 25-hydroxyvitamin D concentrations. Am J Clin Nutr. 1994;60:393-6.
32. Mallet E, Philippe F, Castanet M, Basuyau JP. Administration of a single winter oral dose of 200,000 IU of vitamin D3 in adolescents in Normandy: evaluation of the safety and vitamin D status obtained. Arch Pediatr. 2010;17:1042-6.
33. Oliveri B, Cassinelli H, Mautalen C, Ayala M. Vitamin D prophylaxis in children with a single dose of 150000 IU of vitamin D. Eur J Clin Nutr. 1996;50:807-10.
34. Arpadi SM, McMahon D, Abrams EJ, Bamji M, Purswani M, Engelson ES, et al. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics. 2009;123:e121-6.
35. Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet. 2012;379:1419-27.
36. Manaseki-Holland S, Qader G, Isaq Masher M, Bruce J, Zulf Mughal M, Chandramohan D, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop Med Int Health. 2010;15:1148-55.
37. Tau C, Ciriani V, Scaiola E, Acuna M. Twice single doses of 100,000 IU of vitamin D in winter is adequate and safe for prevention of vitamin D deficiency in healthy children from Ushuaia, Tierra del Fuego, Argentina. J Steroid Biochem Mol Bio. 2007;103:651-4.
38. Vidailhet M, Mallet E, Bocquet A, Bresson JL, Briend A, Chouraqui JP, et al. Vitamin D: still a topical matter in children and adolescents. A position paper by the Committee on Nutrition of the French Society of Paediatrics. Arch Pediatr. 2012;19:316-28.
39. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909-12.
40. Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunol. 2011;134:123-39.
41. Bosse Y, Maghni K, Hudson TJ. 1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol Genomics. 2007;29:161-8.
42. Zitterman A, Pilz S, Hoffman H, Marz W. Vitamin D and airway infections: a European perspective. Eur J Med Res. 2016;21:14.
43. Vieth R. How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res. 2009;29:3675-84.
44. Upham JW, Sly PD. Vitamin D in asthma. Is the golden bullet losing its luster? Am J Resp Crit Care Med. 2016;193:598-600.
45. Ducharme FM, Morin J, Davis GM, Gingras J, Noya FJ. High physician adherence to phenotype-specific asthma guidelines, but large variability in phenotype assessment in children. Curr Med Res Opin. 2012;28:1561-70.
46. Schultz A, Brand PLP. Episodic viral wheeze and multiple trigger wheeze in preschool children: a useful distinction for clinicians? Paed Respir Rev. 2011;12:160-4.